ACC: Measure hsCRP in CVD Prevention Source : Medscape, October 17, 2025
ACC: Measure hsCRP in CVD Prevention
Source : Medscape, October 17, 2025
Keynotes:
1. New ACC statement recommends routine hsCRP testing for both primary and secondary heart disease prevention.
Clinical Application:
• Measure hsCRP along with LDL-C during routine risk assessment.
• Use hsCRP results to:
• Identify patients with high inflammatory risk
2. hsCRP is as strong a predictor of future heart events as LDL cholesterol, even in patients on statins.
3. Other inflammatory markers (IL-6, fibrinogen, N/L ratio) add little beyond hsCRP.
4. Doctors should measure hsCRP + LDL-C to detect hidden inflammation early.
5. Lifestyle measures to reduce inflammation: 150 min/week exercise, Mediterranean or DASH diet, omega-3 intake.
6. Colchicine and other anti-inflammatory drugs may help high-risk patients.
7. Conclusion: Inflammation is now a treatable heart risk, and hsCRP should be part of routine care.